Vitamin K1 vs Vitamin K2: Which Is Better? [Complete Comparison Guide]

Introduction

#

Most people have heard of vitamin K, but far fewer realize there are two fundamentally different forms — and that the difference matters enormously for your health. Vitamin K1 (phylloquinone) and vitamin K2 (menaquinone) share a name and a basic chemical structure, but that is roughly where the similarities end. They come from different food sources, travel through your body by different routes, and activate different proteins that serve different biological functions.

Here is the core distinction that makes this comparison so important: vitamin K1 keeps your blood clotting properly, while vitamin K2 directs calcium to your bones and away from your arteries. If you are only getting K1 from your diet — which describes most Westerners — you may be missing out on the cardiovascular and bone-building benefits that K2 uniquely provides.

This guide breaks down the complete clinical evidence comparing these two forms. We will cover how each one works at the molecular level, what the best human trials actually show, which specific forms and doses have proven benefits, and how to choose the right one for your particular goals. If you take vitamin D supplements or worry about bone density and heart health, understanding vitamin K2 may be one of the most impactful things you do for your long-term health.

Watch Our Video Review

#

What Is Vitamin K1 (Phylloquinone)?

#

The Basics

#

Vitamin K1, also called phylloquinone, is the plant form of vitamin K. It is synthesized by plants as part of photosynthesis, which is why the richest dietary sources are green leafy vegetables — kale, spinach, collard greens, broccoli, and Brussels sprouts. The “K” in vitamin K comes from the German word Koagulation, reflecting the vitamin’s original discovery in 1929 as an essential factor for blood clotting.

Phylloquinone has a single molecular structure. Its quinone ring head group is attached to a phytyl tail (a 20-carbon side chain), making it fat-soluble. When you eat spinach with olive oil or butter, the fat helps your intestinal cells absorb K1 through the same pathway used for other fat-soluble vitamins.

How K1 Works in Your Body

#

Once absorbed in the small intestine, K1 is packaged into chylomicrons (fat-carrying particles) and delivered primarily to the liver. This is a critical detail — K1 is preferentially taken up by the liver, where it performs its primary job: activating blood clotting factors.

The mechanism works through an enzyme called gamma-glutamyl carboxylase (GGCX). This enzyme uses vitamin K1 as a cofactor to add carboxylic acid groups (carboxylation) to specific glutamate residues on precursor proteins. For blood clotting, the key proteins activated through this process are:

• Factor II (prothrombin) — converts to thrombin, the central enzyme in the clotting cascade
• Factor VII — initiates the extrinsic clotting pathway
• Factor IX — part of the intrinsic clotting pathway
• Factor X — the convergence point of both clotting pathways
• Protein C and Protein S — anticoagulant proteins that prevent excessive clotting

Once K1 carboxylates these proteins, it is oxidized to vitamin K epoxide. The enzyme vitamin K epoxide reductase (VKOR) then recycles it back to its active form — this is the exact enzyme that warfarin blocks, which is why warfarin prevents clotting. Your body recycles vitamin K through this oxidation-reduction cycle with remarkable efficiency, which is why you need relatively small daily amounts (PMID: 22516726).

K1 Food Sources and Daily Requirements

#

The Adequate Intake (AI) for vitamin K is set at 120 mcg/day for men and 90 mcg/day for women — but this was established based almost entirely on the amount needed to maintain normal blood clotting, not for optimal bone or cardiovascular health.

Top dietary sources of K1 (per 1 cup cooked):

As you can see, a single serving of any dark leafy green easily exceeds the daily AI several times over. This is why clinical K1 deficiency severe enough to impair clotting is extremely rare in adults who eat vegetables. However — and this is an important nuance — absorption of K1 from whole foods is relatively poor, estimated at only 5-10% from plant sources compared to supplemental forms (PMID: 12540415).

What the Research Shows for K1

#

The evidence for K1’s role in blood clotting is indisputable — this has been established science since the 1930s. K1 (as phytonadione) is the standard medical treatment for:

• Warfarin overdose and supratherapeutic INR
• Vitamin K deficiency bleeding in newborns (prophylactic injection at birth)
• Coagulation disorders due to liver disease or malabsorption

Beyond clotting, some observational studies have linked higher K1 intake to modestly better bone mineral density, but the evidence is far weaker than for K2. The Nurses’ Health Study found that women with the highest K1 intake had a 30% lower risk of hip fracture, but this may reflect overall diet quality rather than a direct K1 effect on bone (PMID: 9925126). Importantly, intervention trials with K1 supplementation have generally not shown significant improvements in bone density or fracture rates when K1 was given alone.

What Is Vitamin K2 (Menaquinone)?

#

The Basics

#

Vitamin K2 is not a single compound but a family of molecules called menaquinones, abbreviated MK-n, where “n” refers to the number of isoprenoid units in the side chain. The two forms most relevant to human health are:

• MK-4 (menaquinone-4) — a short-chain form with 4 isoprenoid units. Found in animal products (egg yolks, butter, liver, chicken). Also produced by human tissue conversion from K1, though in small amounts.
• MK-7 (menaquinone-7) — a long-chain form with 7 isoprenoid units. Found almost exclusively in the Japanese fermented soybean food natto (1,000-1,100 mcg per 100g). Also produced by certain bacteria during fermentation.

Other menaquinone forms exist (MK-8, MK-9, MK-10, etc.) and are found in fermented dairy products and produced by gut bacteria, but MK-4 and MK-7 are the forms with the most clinical research and supplemental availability.

How K2 Works in Your Body — The Calcium Paradox

#

Vitamin K2’s mechanism is where things get genuinely fascinating. Like K1, K2 serves as a cofactor for the gamma-glutamyl carboxylase enzyme. But because K2 — particularly MK-7 — has a longer side chain, it gets packaged into LDL and VLDL cholesterol particles after liver processing and circulates throughout the body for days, reaching tissues that K1 barely touches: bones, arteries, kidneys, cartilage, and soft tissues.

This systemic distribution allows K2 to activate two proteins that are absolutely central to calcium metabolism:

1. Osteocalcin (bone Gla protein) Osteocalcin is produced by osteoblasts (bone-building cells). In its uncarboxylated form, it is inactive. When vitamin K2 carboxylates osteocalcin, it gains the ability to bind calcium ions with high affinity and deposit them directly into the bone mineral matrix. Carboxylated osteocalcin is a major determinant of bone quality and strength (PMID: 36033779).

2. Matrix Gla Protein (MGP) MGP is produced by vascular smooth muscle cells. When K2 carboxylates MGP, it becomes a potent local inhibitor of arterial calcification. Active MGP binds calcium salts in artery walls and prevents them from forming calcified plaques. Without adequate K2, MGP remains undercarboxylated and inactive — and calcium accumulates in your arteries instead of your bones (PMID: 18841280).

This is the “calcium paradox” — the phenomenon where you can simultaneously have calcium leaving your bones (osteoporosis) and depositing in your arteries (atherosclerotic calcification). Vitamin K2 is the molecular switch that resolves this paradox by directing calcium traffic to the right locations. This is also why vitamin K2 is so critically important when you take calcium and vitamin D supplements — without adequate K2, supplemental calcium and vitamin D may increase calcium in the blood without ensuring it goes to bone rather than soft tissue.

MK-4 vs. MK-7: The Two Major K2 Forms

#

Understanding the difference between MK-4 and MK-7 is essential for choosing the right K2 supplement.

MK-4 (Menaquinone-4):

• Half-life: Approximately 1-2 hours in the blood
• Therapeutic dose: 45 mg/day (45,000 mcg) — this is the dose used in Japanese osteoporosis treatment
• Dosing frequency: Must be taken 3 times daily (15 mg per dose) due to rapid clearance
• Tissue distribution: Rapidly taken up by tissues but quickly cleared from blood
• Clinical use: Approved in Japan since 1995 for osteoporosis treatment; multiple RCTs show fracture reduction at 45 mg/day
• Food sources: Egg yolks, butter, cheese, chicken liver, beef liver

MK-7 (Menaquinone-7):

• Half-life: Approximately 68-72 hours (roughly 3 days)
• Therapeutic dose: 100-200 mcg/day (a fraction of the MK-4 dose)
• Dosing frequency: Once daily is sufficient due to long circulation time
• Tissue distribution: Carried on LDL particles, reaches extrahepatic tissues efficiently over days
• Clinical use: Most clinical trials on cardiovascular outcomes use MK-7; the Knapen arterial stiffness trial used 180 mcg MK-7 for 3 years
• Food sources: Natto (fermented soybeans) — by far the richest source

The key practical difference: MK-7 is roughly 6-7 times more bioavailable than MK-4 at nutritional doses because of its longer side chain and extended circulation time. At nutritional-level doses (under 1 mg), MK-4 is poorly absorbed and undetectable in blood — it requires pharmacological doses (45 mg) to produce clinical effects. MK-7 is well absorbed and fully detectable in serum at doses as low as 45 mcg (PMID: 23140417).

For most people supplementing for general bone and cardiovascular health, MK-7 at 100-200 mcg/day is the most practical and well-supported choice. MK-4 at 45 mg/day is a valid clinical option for diagnosed osteoporosis, but the high dose, multiple daily doses, and higher cost make it less convenient for prevention.

What the Research Shows for K2

#

The clinical evidence for K2 is substantial and growing. Here are the landmark studies:

The Rotterdam Study (PMID: 15514282) This population-based cohort study followed 4,807 Dutch subjects over 7-10 years. It found that the highest tertile of dietary menaquinone (K2) intake was associated with a 57% reduction in coronary heart disease mortality, a 52% reduction in severe aortic calcification, and a 26% reduction in all-cause mortality compared to the lowest tertile. Crucially, vitamin K1 intake showed no such associations — the cardiovascular benefits were specific to K2.

Knapen Arterial Stiffness Trial (PMID: 25694037) A double-blind, randomized, placebo-controlled trial of 244 healthy postmenopausal women. Those taking 180 mcg MK-7 daily for 3 years showed significantly improved arterial stiffness — measured by carotid intima-media thickness and pulse wave velocity — compared to placebo. The benefits were most pronounced in women who already had elevated arterial stiffness at baseline.

Japanese MK-4 Osteoporosis Trials Multiple Japanese RCTs demonstrated that 45 mg/day MK-4 reduced vertebral fracture incidence by 60-80% in postmenopausal women with osteoporosis. A meta-analysis of seven trials confirmed significant improvements in lumbar spine BMD and fracture reduction (PMID: 16801507). MK-4 at this dose has been an approved osteoporosis treatment in Japan since 1995.

MK-7 Bone Density Trial (PMID: 23525894) A 3-year, double-blind, placebo-controlled trial of 244 postmenopausal women taking 180 mcg MK-7 daily found significantly less decline in bone mineral density at the lumbar spine and femoral neck compared to placebo, along with significantly improved bone strength indices.

2022 Meta-Analysis (PMID: 36033779) A systematic review of 16 RCTs involving 6,425 subjects confirmed that vitamin K2 supplementation significantly improved lumbar spine BMD and reduced undercarboxylated osteocalcin levels — the functional marker of vitamin K sufficiency in bone tissue.

Key Differences Between Vitamin K1 and Vitamin K2

#

Chemical Structure and Absorption

#

Both K1 and K2 share the same 2-methyl-1,4-naphthoquinone ring, but their side chains differ dramatically. K1’s phytyl tail makes it moderately lipophilic and preferentially absorbed by the liver. K2’s isoprenoid chains — particularly the 7-unit chain in MK-7 — make it more hydrophobic and allow it to be incorporated into low-density lipoproteins for extended systemic circulation.

This structural difference translates to profoundly different pharmacokinetics:

Biological Roles

#

Vitamin K1 primarily activates:

• Clotting factors II, VII, IX, X (coagulation)
• Protein C and Protein S (anticoagulation)
• These are all hepatic (liver) proteins

Vitamin K2 primarily activates:

• Osteocalcin — directs calcium into bone matrix
• Matrix Gla Protein (MGP) — prevents arterial calcification
• Growth Arrest-Specific protein 6 (Gas6) — involved in cell signaling, inflammation regulation
• These are extrahepatic proteins found in bone, arteries, and other tissues

The Dietary Gap

#

Here is a fact that changes the entire supplementation equation: most people get plenty of K1 from food but almost no K2.

A typical Western diet provides 70-250 mcg of K1 daily from vegetables — generally sufficient for blood clotting. But the same diet provides only 5-25 mcg of K2, almost entirely as MK-4 from eggs, meat, and dairy. Unless you eat natto regularly (virtually nobody outside Japan does), you are almost certainly not getting enough K2 to fully carboxylate your osteocalcin and MGP.

Research confirms this: even in populations with adequate K1 intake, 20-30% of osteocalcin and a significant proportion of MGP remain undercarboxylated — indicating subclinical K2 insufficiency that impairs bone mineralization and arterial protection without causing any clotting problems (PMID: 22516726).

This is why vitamin K2 supplementation provides measurable clinical benefits even in well-nourished populations, while K1 supplementation rarely moves the needle beyond what diet already provides.

Head-to-Head Comparison

#

The Vitamin K2 + D3 Synergy: Why They Belong Together

#

If you take vitamin D — and many health professionals now recommend it, especially at latitudes above 35 degrees — understanding the K2-D3 connection is essential.

Vitamin D3 increases the production of vitamin K-dependent proteins. Specifically, D3 upregulates the gene expression of osteocalcin in osteoblasts and MGP in vascular smooth muscle cells. This means that when you take vitamin D3, your body produces more of these proteins — but they are produced in their inactive, undercarboxylated form. Without enough vitamin K2 to carboxylate them, you have more inactive osteocalcin (cannot bind calcium to bone) and more inactive MGP (cannot prevent arterial calcification).

This creates a potentially harmful scenario: vitamin D3 increases calcium absorption from the gut and increases production of calcium-handling proteins, but without K2, that calcium has nowhere safe to go. Some researchers have hypothesized this may partly explain why high-dose vitamin D supplementation alone has not consistently reduced fracture risk in clinical trials — the calcium being absorbed may not be properly directed to bone.

A meta-analysis of eight RCTs involving 971 subjects found that combining vitamins K2 and D3 significantly increased total bone mineral density and decreased undercarboxylated osteocalcin levels compared to either vitamin alone (PMID: 28971549). A Korean study in postmenopausal women found that adding K2 to vitamin D3 and calcium supplementation increased BMD and reduced undercarboxylated osteocalcin after 6 months compared to vitamin D3 and calcium alone.

Practical recommendation: If you supplement vitamin D3, always pair it with at least 100 mcg of K2 (MK-7). Many combined D3+K2 supplements now exist for this reason. The optimal ratio is not precisely established, but a common evidence-based combination is 2,000-5,000 IU D3 with 100-200 mcg MK-7 daily.

Clues Your Body Tells You: Signs You May Need More Vitamin K

#

Your body sends signals when vitamin K status is suboptimal. These clues differ depending on whether you are lacking K1 (rare) or K2 (very common).

Signs of Vitamin K1 Deficiency (Clotting Problems)

#

True K1 deficiency is uncommon in adults but can occur with severe malabsorption, chronic antibiotic use (which disrupts gut bacteria that produce small amounts of K2), liver disease, or extreme dietary restriction. Watch for:

• Easy bruising — bruises appearing from minor bumps or without clear cause
• Bleeding gums — particularly when brushing teeth, despite good dental hygiene
• Nosebleeds that are more frequent or harder to stop than usual
• Prolonged bleeding from cuts — small wounds that take noticeably longer to clot
• Heavy menstrual periods — unusually heavy or prolonged flow
• Blood in stool or urine — a serious sign requiring immediate medical evaluation
• Petechiae — tiny red dots under the skin from broken capillaries

If you experience multiple bleeding-related symptoms, your doctor can check your prothrombin time (PT) or INR — elevated values suggest impaired vitamin K-dependent clotting.

Signs of Subclinical Vitamin K2 Insufficiency (The Silent Problem)

#

This is far more insidious because subclinical K2 insufficiency causes no obvious bleeding problems. Your K1 levels may be perfectly adequate for clotting while your extrahepatic tissues are starved of K2. The signs are subtler and develop over years:

• Declining bone density on DEXA scans — despite adequate calcium and vitamin D intake
• Dental problems — increased cavities, weakened enamel, or tooth sensitivity (teeth are mineralized tissue that depends on osteocalcin)
• Arterial stiffness — elevated blood pressure that is not fully explained by other risk factors
• Coronary artery calcium (CAC) score increasing — a direct measure of arterial calcification
• Joint stiffness or calcification — calcium depositing in soft tissues around joints
• Bone spurs — calcium deposits in tendons and ligaments (a sign of misdirected calcium)
• Kidney stones (calcium oxalate type) — calcium that should be in bones ending up in kidneys
• Fatigue and low energy — though this is nonspecific, it can accompany poor calcium metabolism
• History of fractures from minor falls — fragility fractures suggest compromised bone quality

The challenge is that these signs overlap with many other conditions. The most specific marker is a blood test for undercarboxylated osteocalcin (ucOC) or dephosphorylated-uncarboxylated MGP (dp-ucMGP) — elevated levels of either confirm insufficient K2 activity in bone and vascular tissue respectively. Ask your doctor about these tests if you suspect K2 insufficiency, especially if you are postmenopausal, have osteopenia, or have a rising CAC score.

What Improvement Looks Like — Signs K2 Supplementation Is Working

#

When you begin supplementing vitamin K2 (especially MK-7 at 100-200 mcg daily), expect a gradual timeline of changes:

Week 1-2:

• Undercarboxylated osteocalcin levels begin dropping in blood tests (measurable within 2 weeks in studies)
• You may not feel any subjective difference yet — K2 works on slow biological processes

Month 1-2:

• dp-ucMGP (the inactive form of the arterial protection protein) begins declining
• Some people report improved dental health — less sensitivity, stronger-feeling teeth
• If you had joint stiffness from soft tissue calcification, early improvement may begin

Month 3-6:

• Bone turnover markers shift toward more formation and less resorption
• If combined with D3, calcium, and resistance exercise, bone density changes become measurable
• Arterial stiffness indices may begin improving (the Knapen trial showed significant effects by year 1-3)
• Energy levels may improve if poor calcium metabolism was contributing to fatigue

Year 1-3:

• DEXA scans may show stabilized or improved bone mineral density (consistent with 3-year MK-7 trial data)
• CAC scores may stabilize or progress more slowly than expected
• Arterial elasticity measurably improved (Knapen trial endpoint)
• Fracture risk reduced (based on improved bone quality markers)

Warning Signs to Watch For

#

While vitamin K2 has an exceptional safety profile, certain situations warrant immediate medical attention:

• Unexplained blood clots (especially if you have a history of thrombosis) — see a doctor before starting any vitamin K supplement
• Changes in bruising or bleeding patterns if you take any anticoagulant medication
• INR changes if you are on warfarin — any new supplement should be reported to your anticoagulant clinic
• Severe bone pain — this is not a K2 effect and may indicate a different condition requiring evaluation

Comprehensive Dosing Guide

#

Vitamin K1 Dosing

#

For most healthy adults, K1 supplementation is unnecessary if you eat green vegetables regularly. However, specific situations call for K1:

Vitamin K2 Dosing

#

Timing considerations:

• Take K2 with a fat-containing meal — it is fat-soluble and absorption improves 2-3x with dietary fat
• MK-7 can be taken at any time of day since it circulates for days
• MK-4 should be split into 3 daily doses (morning, afternoon, evening) due to its short half-life
• If taking with D3, morning dosing with breakfast is ideal

Special Population Dosing

#

• Postmenopausal women: 180-200 mcg MK-7 daily (consistent with the positive clinical trial data)
• Adults on vitamin D3: Minimum 100 mcg MK-7 daily to carboxylate the extra osteocalcin and MGP that D3 stimulates
• People with kidney disease: K2 status is often severely depleted; 180-360 mcg MK-7 under medical supervision (PMID: 37299386)
• Children and adolescents: 45-90 mcg MK-7 daily (growing bones have high osteocalcin demands)
• Pregnant women: Current data supports K2 safety in pregnancy; 100 mcg MK-7 is commonly recommended but discuss with your OB

Drug Interactions and Safety Warnings

#

The Critical Warfarin Interaction

#

This is the single most important drug interaction for any vitamin K supplement and deserves detailed explanation.

Warfarin (Coumadin) works by blocking the enzyme vitamin K epoxide reductase (VKOR). This prevents the recycling of vitamin K from its oxidized (epoxide) form back to its active (hydroquinone) form. With less active vitamin K available, the liver produces fewer functional clotting factors, and blood clots less readily.

Any form of vitamin K can overcome warfarin’s effect by providing fresh substrate for the carboxylation reaction, bypassing the blocked recycling pathway. However, the potency of this interaction differs between K1 and K2:

• K1 is the most potent warfarin antagonist because it is preferentially taken up by the liver — the exact tissue where clotting factors are produced. Even 100-250 mcg of supplemental K1 can shift INR over days.
• MK-7 at low doses (45-100 mcg) has a modest effect on INR. One study showed that MK-7 doses under 50 mcg/day did not significantly alter INR in warfarin-stabilized patients. However, higher doses progressively antagonize warfarin in a dose-dependent manner (PMID: 27440682).
• MK-4 at pharmacological doses (45 mg) potently reverses warfarin — in fact, K2 (as MK-4) is used in Japan instead of K1 for warfarin-related coagulopathy reversal (PMID: 25636520).

Bottom line for warfarin patients: Do NOT start any vitamin K supplement without your prescribing physician’s explicit approval. If K2 is approved, it must be taken at a consistent daily dose so the warfarin dose can be adjusted to account for it. Inconsistent K2 intake causes dangerous INR fluctuations.

Newer anticoagulants (DOACs): Apixaban (Eliquis), rivarelbaxin (Xarelto), dabigatran (Pradaxa), and edoxaban (Savaysa) work by directly inhibiting specific clotting factors rather than blocking vitamin K recycling. Vitamin K does not significantly interact with these medications. However, you should still inform your prescriber before starting any supplement.

Other Drug Interactions

#

• Antibiotics (broad-spectrum): Prolonged courses can destroy gut bacteria that produce small amounts of K2, potentially worsening K2 insufficiency
• Cholestyramine and orlistat: These fat-blocking medications reduce absorption of all fat-soluble vitamins including K1 and K2
• High-dose vitamin E (>800 IU): May interfere with vitamin K-dependent carboxylation at very high doses
• Statins: Some evidence suggests statins may reduce MK-4 synthesis from K1 in tissues, though this remains debated
• Proton pump inhibitors (PPIs): Long-term use may impair K2 status by altering gut microbiome composition

Side Effects

#

Vitamin K1 Side Effects

#

Vitamin K1 at dietary or supplemental levels has no known adverse effects. No Tolerable Upper Intake Level (UL) has been established because toxicity has never been observed. Injectable K1 (phytonadione) used in medical settings can rarely cause anaphylactic-type reactions, but this is related to the injection vehicle, not vitamin K itself.

Vitamin K2 Side Effects

#

Vitamin K2 also has an exceptional safety record:

• MK-7 at up to 360 mcg/day for 3 years: No adverse effects in the Knapen trial (PMID: 25694037)
• MK-7 at up to 375 mcg/day: No meaningful impact on blood coagulation in healthy adults (CRN safety assessment)
• MK-4 at 45 mg/day: Well-tolerated in Japanese clinical use since 1995; occasional mild GI discomfort reported at this high dose
• Toxicological testing: Oral LD50 in mice exceeds 2,000 mg/kg body weight — an enormous safety margin

• No known toxicity: Unlike vitamins A and D, there is no established toxicity threshold for K2

The only clinically relevant “side effect” is the warfarin interaction discussed above, which is technically a drug interaction rather than an adverse effect of K2 itself.

Rare reports include:

• Mild nausea or stomach upset (usually with MK-4 at high doses taken on an empty stomach)
• Allergic reactions (extremely rare, likely related to inactive ingredients rather than K2)

Cost Comparison

#

Understanding the true cost-effectiveness requires looking beyond sticker price to consider necessity, dosing, and what benefits you are actually getting.

Vitamin K1 Supplements

#

But consider this: A single cup of cooked kale provides over 1,000 mcg of K1 for approximately $0.50-1.00. Most people eating a reasonable diet already get enough K1, making supplementation an unnecessary expense unless you have a specific medical indication.

Vitamin K2 Supplements

#

Value analysis:

• Best overall value: MK-7 at 100-200 mcg daily. At $0.08-0.47 per day, this provides the K2 form with the strongest cardiovascular evidence, longest half-life, and most convenient once-daily dosing.
• D3+K2 combos offer excellent value since most K2 supplementers should also take D3 — buying them together saves money versus separate bottles.
• MK-4 at the 45mg therapeutic dose is the most expensive option at $1.25-2.00/day, but may be worthwhile for diagnosed osteoporosis under medical guidance.

Which Should You Choose?

#

Choose Vitamin K1 If:

#

• You have a diagnosed clotting disorder caused by vitamin K deficiency
• You need to reverse warfarin anticoagulation under medical supervision
• You have severe malabsorption (celiac, Crohn’s, short bowel) and cannot absorb K1 from food
• You eat very few vegetables and want basic clotting factor insurance (though eating more vegetables is the better solution)
• You are a healthcare provider treating neonatal vitamin K deficiency bleeding
• Your doctor specifically prescribes K1 (phytonadione) for a medical condition

For the vast majority of people eating a diet that includes any green vegetables, supplemental K1 is unnecessary.

Choose Vitamin K2 If:

#

• You want to optimize bone health — especially if you are postmenopausal, over 50, or have osteopenia/osteoporosis
• You take vitamin D3 — K2 ensures the extra osteocalcin and MGP that D3 stimulates actually get activated
• You take calcium supplements — K2 helps direct that calcium to bone instead of arteries
• You are concerned about cardiovascular health — arterial calcification is a major risk factor for heart attacks and strokes
• You have an elevated coronary artery calcium (CAC) score — K2 is one of the few nutrients shown to address arterial calcification
• You have a family history of osteoporosis or heart disease
• You do not eat natto regularly — this eliminates roughly 99% of the Western population
• You have kidney disease — CKD patients are commonly K2-depleted with high dp-ucMGP
• You want dental health support — teeth are mineralized tissue dependent on vitamin K-activated proteins
• You have joint calcification, bone spurs, or calcium-type kidney stones — signs of misdirected calcium

Choose Both K1 + K2 If:

#

• You eat very few vegetables AND want bone/heart protection — rare but some people need both supplementally
• You have malabsorption syndromes — impairs absorption of all fat-soluble vitamins
• You want comprehensive coverage — many people take a “full spectrum K” supplement containing K1, MK-4, and MK-7

The Most Common Correct Answer

#

For the average health-conscious adult: You do not need to supplement K1 (eat your vegetables), and you should strongly consider supplementing K2 as MK-7 at 100-200 mcg daily, especially if you take vitamin D3 or calcium, are over 40, or have any bone or cardiovascular risk factors. This is the recommendation supported by the balance of current evidence.

Best Bioavailable Forms

#

Not all K1 or K2 supplements are created equal. Here is what to look for:

Vitamin K1

#

• Phytonadione — the standard supplemental form; well absorbed with fat
• Look for oil-based softgels rather than dry tablets for better absorption
• No patented forms dominate the K1 market — generic phytonadione is fine

Vitamin K2 (MK-7)

#

• MenaQ7 — the most clinically studied branded MK-7, used in the Knapen arterial stiffness trial. Produced by NattoPharma (now Gnosis by Lesaffre). If a supplement lists MenaQ7 on the label, it uses this specific form.
• K2VITAL — another patented MK-7 form by Kappa Bioscience with good stability data
• Generic MK-7 — acceptable but verify third-party testing; some generic MK-7 products have tested low for actual content
• All-trans MK-7 — the bioactive isomer; avoid “cis” MK-7, which has no biological activity. Reputable brands specify “all-trans.”
• Soy-free MK-7 — available for those with soy allergies (produced by fermentation of non-soy substrates)

Vitamin K2 (MK-4)

#

• Menatetrenone — the standard pharmaceutical name
• Most MK-4 supplements are synthetic (identical to natural MK-4 in structure)
• For the 45mg osteoporosis dose, look for capsules containing 15mg each (take 3 daily)

Combination Supplements

#

Several well-designed supplements combine multiple vitamin K forms:

• Life Extension Super K — contains K1 (1,500 mcg) + MK-4 (1,000 mcg) + MK-7 (100 mcg)
• Jarrow Formulas MK-7 — pure MK-7 (90 or 180 mcg) from MenaQ7
• Thorne Vitamin D/K2 Liquid — combines D3 with MK-4 in a convenient dropper
• Innovix Labs Full Spectrum K2 — contains both MK-4 (500 mcg) and MK-7 (100 mcg)

Who Is Most at Risk for Vitamin K Insufficiency?

#

While severe K1 deficiency is rare, subclinical K2 insufficiency is remarkably common. These populations are at highest risk:

• Postmenopausal women — declining estrogen accelerates bone loss; K2 insufficiency compounds the problem
• Adults over 60 — declining dietary intake, reduced intestinal absorption, and more medications that interfere with K status
• People taking vitamin D without K2 — D3 increases demand for K-dependent proteins without supplying the K needed to activate them
• Chronic kidney disease patients — studies show CKD patients have severely elevated dp-ucMGP, indicating profound K2 insufficiency
• People on long-term antibiotics — disrupt gut bacteria that contribute modest amounts of K2
• People on cholestyramine, orlistat, or PPIs — impair fat-soluble vitamin absorption or gut flora
• People on warfarin or DOACs — these medications either block K recycling or create a clinical situation where K status must be carefully managed
• People who avoid dairy and fermented foods — missing dietary K2 sources
• Individuals with Crohn’s disease, celiac, or other malabsorption conditions
• Newborns — born with very low vitamin K stores; this is why K1 injection at birth is standard of care worldwide

Myths and Misconceptions

#

Myth: “Vitamin K1 and K2 are basically the same thing”

#

Reality: They share a name and a basic ring structure, but their side chains, pharmacokinetics, tissue distribution, and biological roles are fundamentally different. K1 stays in the liver for clotting; K2 circulates systemically for bone and cardiovascular health. The Rotterdam Study showed cardiovascular benefits for K2 but not K1, confirming they are not interchangeable.

Myth: “Your gut bacteria make enough K2, so you don’t need to supplement”

#

Reality: Gut bacteria do produce menaquinones (mainly MK-10 and MK-11), but these long-chain forms are largely trapped within bacterial membranes and poorly absorbed. Research shows that gut bacterial K2 production contributes minimally to human K2 status — certainly not enough to fully carboxylate osteocalcin and MGP. The evidence of widespread undercarboxylated osteocalcin in Western populations confirms that gut production is insufficient (PMID: 22516726).

Myth: “You can get enough K2 from eating K1-rich foods because the body converts K1 to K2”

#

Reality: Human tissues can convert K1 to MK-4 through a side chain exchange enzyme (UBIAD1), but the conversion rate is very low. Animal studies suggest only 5-25% of K1 is converted, and the resulting MK-4 has a half-life of only 1-2 hours. This conversion is nowhere near sufficient to provide the K2 levels achieved by supplementation or natto consumption.

Myth: “Vitamin K2 causes dangerous blood clots”

#

Reality: Vitamin K2 supports the activation of both pro-coagulant AND anticoagulant proteins (Protein C and Protein S). It does not shift the clotting balance toward hypercoagulability in healthy individuals. Studies giving 180-360 mcg MK-7 daily for years showed no increased clotting risk. The only concern is in patients already taking anticoagulant medications, where K2 can reduce the drug’s effectiveness — not because K2 causes clots, but because it counteracts the medication.

Myth: “High-dose K2 is dangerous”

#

Reality: No Tolerable Upper Intake Level exists for vitamin K2 because toxicity has never been demonstrated. Japanese patients have taken 45 mg (45,000 mcg) of MK-4 daily for years without toxicity. Toxicological studies in animals found the oral LD50 for MK-7 exceeds 2,000 mg/kg body weight. Vitamin K2 is one of the safest supplements available.

Myth: “You only need vitamin K if you have blood clotting issues”

#

Reality: This is perhaps the most damaging myth. Blood clotting is only one of vitamin K’s roles — and it is handled adequately by K1 from a normal diet. The bone-building and arterial-protecting functions of K2 are arguably more important for long-term health, and most people are insufficient in K2 without knowing it. Framing vitamin K as solely a “clotting vitamin” has led to decades of widespread K2 insufficiency being ignored.

Common Questions About Vitamin K1

#

What are the benefits of vitamin k1?

Vitamin K1 has been studied for various potential health benefits. Research suggests it may support several aspects of health and wellness. Individual results can vary. The strength of evidence differs across different claimed benefits. More high-quality research is often needed. Always review the latest scientific literature and consult healthcare professionals about whether vitamin k1 is right for your health goals.

Is vitamin k1 safe?

Vitamin K1 is generally considered safe for most people when used as directed. However, individual responses can vary. Some people may experience mild side effects. It’s important to talk with a healthcare provider before using vitamin k1, especially if you have existing health conditions, are pregnant or nursing, or take medications.

How much vitamin k1 should I take?

The appropriate dosage of vitamin k1 can vary based on individual factors, health goals, and the specific product formulation. Research studies have used different amounts. Always start with the lowest effective dose and follow product label instructions. Consult a healthcare provider for personalized dosage recommendations based on your specific needs.

What are the side effects of vitamin k1?

Most people tolerate vitamin k1 well, but some may experience mild side effects. Common reported effects can include digestive discomfort, headaches, or other minor symptoms. Serious side effects are rare but possible. If you experience any unusual symptoms or reactions, discontinue use and consult a healthcare provider. Always inform your doctor about all supplements you take.

When should I take vitamin k1?

The optimal timing for taking vitamin k1 can depend on several factors including its absorption characteristics, potential side effects, and your daily routine. Some supplements work best with food, while others are better absorbed on an empty stomach. Follow product-specific guidelines and consider consulting a healthcare provider for personalized timing recommendations.

Can I take vitamin k1 with other supplements?

Vitamin K1 is a topic of ongoing research in health and nutrition. Current scientific evidence provides some insights, though more studies are often needed. Individual responses can vary significantly. For personalized advice about whether and how to use vitamin k1, consult with a qualified healthcare provider who can consider your complete health history and current medications.

How long does vitamin k1 take to work?

The time it takes for vitamin k1 to work varies by individual and depends on factors like dosage, consistency of use, and individual metabolism. Some people notice effects within days, while others may need several weeks. Research studies typically evaluate effects over weeks to months. Consistent use as directed is important for best results. Keep a journal to track your response.

Who should not take vitamin k1?

Vitamin K1 is a topic of ongoing research in health and nutrition. Current scientific evidence provides some insights, though more studies are often needed. Individual responses can vary significantly. For personalized advice about whether and how to use vitamin k1, consult with a qualified healthcare provider who can consider your complete health history and current medications.

Frequently Asked Questions

#

Detailed answers to the most common questions about vitamin K1 vs K2 are provided in the FAQ metadata at the top of this page. Here we expand on additional questions:

Can vitamin K2 reverse arterial calcification?

#

The evidence is promising but not conclusive. The Knapen trial showed that 180 mcg MK-7 daily for 3 years significantly improved arterial stiffness and inhibited age-related deterioration of arterial elasticity. However, actually reversing established calcification is more challenging than preventing new calcification. Animal studies have shown regression of calcification with K2 supplementation. In humans, the best evidence suggests K2 can slow or halt progression of arterial calcification, with modest regression possible over years of consistent supplementation, particularly in individuals who were K2-deficient at baseline. The most prudent interpretation is that K2 protects against further calcification and may modestly reverse existing calcification in some patients, especially when combined with adequate magnesium and the elimination of excess calcium and phosphorus intake.

Is it possible to take too much vitamin K2?

#

Based on current evidence, vitamin K2 toxicity has not been demonstrated in humans at any dose tested. Japanese patients take 45 mg (45,000 mcg) of MK-4 daily as a medical treatment. Clinical trials have tested MK-7 at up to 360 mcg daily for years without adverse effects. The Council for Responsible Nutrition established a Highest Observed Intake of 375 mcg/day for MK-7, meaning this is the highest dose tested in clinical trials with no safety concerns — this is not a toxicity limit but simply the highest dose studied. Most practitioners recommend staying within the 100-200 mcg MK-7 range for general health, which is well within demonstrated safety margins.

Should I take K2 if I have a family history of blood clots?

#

Vitamin K2 at supplemental doses (100-200 mcg MK-7) does not increase clotting risk in healthy individuals. It supports the activation of both pro-coagulant factors (II, VII, IX, X) and anticoagulant factors (Protein C, Protein S), maintaining hemostatic balance rather than shifting it. However, if you have a diagnosed thrombophilia (Factor V Leiden, prothrombin gene mutation, etc.) or are taking anticoagulant medication, consult your hematologist before starting K2. The distinction is important: having a family history of clots is not the same as having a diagnosed clotting disorder.

Does cooking destroy vitamin K1 in vegetables?

#

Cooking actually improves K1 bioavailability. Raw green vegetables contain K1 tightly bound within plant cell membranes. Cooking breaks these membranes, releasing K1 and making it more accessible for intestinal absorption. Boiling causes some K1 to leach into cooking water (save that liquid for soup), but steaming, sauteing, and roasting preserve K1 well. Adding fat to cooked greens (olive oil, butter) further enhances absorption since K1 is fat-soluble.

What about the MTHFR gene mutation and vitamin K?

#

The MTHFR gene mutation (particularly C677T and A1298C variants) affects folate metabolism but does not directly impair vitamin K metabolism. However, there is an indirect connection: individuals with MTHFR mutations often have elevated homocysteine levels, and elevated homocysteine is associated with increased arterial calcification and accelerated bone loss. Vitamin K2’s ability to activate MGP (preventing arterial calcification) and osteocalcin (supporting bone mineralization) may be especially valuable in individuals with MTHFR variants who are already at elevated cardiovascular and bone risk due to homocysteine-related pathology. While K2 does not fix the MTHFR issue itself (that requires active folate, B12, and B6), it may help mitigate some of the downstream consequences.

Recommended Products

#

Related Articles

#

• [Elderberry vs Vitamin C For Immune Support: Which Is Better? [Complete Comparison Guide]](/comparisons/elderberry-vs-vitamin-c-for-immune-support/)
• Vitamin B12 vs B Complex: Which Is Better? [Complete Comparison Guide]
• [Vitamin C vs Zinc For Immune Support: Which Is Better? [Complete Comparison Guide]](/comparisons/vitamin-c-vs-zinc-for-immune-support/)
• Vitamin D2 vs Vitamin D3: Which Is Better? [Complete Comparison Guide]
• [Multivitamin vs Individual Supplements: Which Is Better? [Complete Comparison Guide]](/comparisons/multivitamin-vs-individual-supplements/)

References

#

1. Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;134(11):3100-3105. PubMed: PMID 15514282

2. Knapen MH, Braam LA, Drummen NE, Bekers O, Hoeks AP, Vermeer C. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: a double-blind randomised clinical trial. Thromb Haemost. 2015;113(5):1135-1144. PubMed: PMID 25694037

3. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166(12):1256-1261. PubMed: PMID 16801507

4. Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499-2507. PubMed: PMID 23525894

5. Schurgers LJ, Teunissen KJ, Hamulyak K, Knapen MH, Vik H, Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007;109(8):3279-3283. PubMed: PMID 17158229

6. Schurgers LJ, Vermeer C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta. 2002;1570(1):27-32. PubMed: PMID 11960685

7. Cranenburg EC, Schurgers LJ, Vermeer C. Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost. 2007;98(1):120-125. PubMed: PMID 17598002

8. Schurgers LJ, Cranenburg EC, Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost. 2008;100(4):593-603. PubMed: PMID 18841280

9. van Ballegooijen AJ, Pilz S, Tomaschitz A, Grubler MR, Verheyen N. The synergistic interplay between vitamins D and K for bone and cardiovascular health: a narrative review. Int J Endocrinol. 2017;2017:7454376. PubMed: PMID 28978037

10. Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr. 1999;69(1):74-79. PubMed: PMID 9925126

11. Ma ML, Ma ZJ, He YL, et al. Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: a systematic review and meta-analysis of randomized controlled trials. Front Public Health. 2022;10:979649. PubMed: PMID 36033779

12. Booth SL. Vitamin K: food composition and dietary intakes. Food Nutr Res. 2012;56:5505. PubMed: PMID 22489217

13. Sato T, Schurgers LJ, Uenishi K. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr J. 2012;11:93. PubMed: PMID 23140417

14. Theuwissen E, Cranenburg EC, Knapen MH, et al. Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Br J Nutr. 2012;108(9):1652-1657. PubMed: PMID 22289649

15. Vermeer C. Vitamin K: the effect on health beyond coagulation — an overview. Food Nutr Res. 2012;56:5329. PubMed: PMID 22516726

16. Ito Y, Hara T, Imanishi Y, et al. Effect of vitamin K2 on the anticoagulant activity of warfarin during the perioperative period of catheter ablation. J Pharm Health Care Sci. 2016;2:22. PubMed: PMID 27440682

17. Pucaj K, Rasmussen H, Moller M, Preston T. Safety and toxicological evaluation of a synthetic vitamin K2, menaquinone-7. Toxicol Mech Methods. 2011;21(7):520-532. PubMed: PMID 21781006

18. Riphagen IJ, van der Molen JC, van Faassen M, et al. Vitamin K2 for the reversal of warfarin-related coagulopathy. Thromb Res. 2015;135(4):e15. PubMed: PMID 25636520

Where to Buy Quality Supplements

#

Based on the research discussed in this article, here are some high-quality options:

• Vitamin D Supplement
• Vitamin D3 Supplement
• Vitamin C Supplement
• Vitamin B12 Supplement
• Magnesium Supplement